|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM30280837X |
| 003 |
DE-627 |
| 005 |
20231225111514.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2019.108292
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1009.xml
|
| 035 |
|
|
|a (DE-627)NLM30280837X
|
| 035 |
|
|
|a (NLM)31676420
|
| 035 |
|
|
|a (PII)S1521-6616(19)30434-6
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Damiani, Giovanni
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim)
|b A potential ally to combat serious infections
|
| 264 |
|
1 |
|c 2020
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 31.07.2020
|
| 500 |
|
|
|a Date Revised 14.05.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2019 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Granulocyte-macrophage-colony stimulating factor (GM-CSF), can direct the activation, proliferation and differentiation of myeloid-derived cells. It is also responsible for maturation and function of professional antigen presenting cells thereby impacting adaptive immune responses, while assisting to maintain epithelial barrier function. GM-CSF in combination with other endogenous cytokines and secondary stimuli, such as tumor necrosis factor can modulate pro-inflammatory monocyte priming via chromatin remodeling and enhanced transcriptional responses, a concept termed "trained immunity". An increase in the incidence of opportunistic fungal infections was recently reported in patients with hematological cancers receiving treatment with the BTK inhibitor, Ibrutinib. Tec Kinase BTK is known to influence the expression of GM-CSFRα and regulates downstream signaling pathways, suggesting a role for GM-CSF in maintenance of defense against fungal infections in immune competent hosts. Further examination of the potential mechanism(s) of action for naturally occurring GM-CSF and recombinant human GM-CSF (rhu-GM-CSF) expressed in yeast (sargramostim) are reviewed
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Chronic refractory intracellular pathogens
|
| 650 |
|
4 |
|a GM-CSF
|
| 650 |
|
4 |
|a Immune response
|
| 650 |
|
7 |
|a Recombinant Proteins
|2 NLM
|
| 650 |
|
7 |
|a Tumor Necrosis Factor-alpha
|2 NLM
|
| 650 |
|
7 |
|a sargramostim
|2 NLM
|
| 650 |
|
7 |
|a 5TAA004E22
|2 NLM
|
| 650 |
|
7 |
|a Granulocyte-Macrophage Colony-Stimulating Factor
|2 NLM
|
| 650 |
|
7 |
|a 83869-56-1
|2 NLM
|
| 700 |
1 |
|
|a McCormick, Thomas S
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Leal, Luis O
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ghannoum, Mahmoud A
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 210(2020) vom: 01. Jan., Seite 108292
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:210
|g year:2020
|g day:01
|g month:01
|g pages:108292
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2019.108292
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 210
|j 2020
|b 01
|c 01
|h 108292
|